📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Resistant type II cryoglobulinaemic vasculitis successfully treated with bortezomib in a patient with SLE. (2019)

First Author: Dutton K

Attributed to: MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches (MASTERPLANS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bcr-2018-226083

PubMed Identifier: 30612104

Publication URI: http://europepmc.org/abstract/MED/30612104

Type: Journal Article/Review

Volume: 12

Parent Publication: BMJ case reports

Issue: 1

ISSN: 1757-790X